Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Antibodies > Primary antibodies

Anti-Human IL-13 Recombinant Antibody (SAA2016) (HW632013)

Anti-Human IL-13 Recombinant Antibody (SAA2016)
Anti-Human IL-13 Recombinant Antibody (SAA2016)
Anti-Human IL-13 Recombinant Antibody (SAA2016)
Anti-Human IL-13 Recombinant Antibody (SAA2016)
Anti-Human IL-13 Recombinant Antibody (SAA2016)
Anti-Human IL-13 Recombinant Antibody (SAA2016)
Price(USD):
Spec:
  • 20ug
  • 50ug
  • 100ug
  • 1mg
Number:
Get quote
  • Overview

  • Images

  • References

  • Datasheet

  • SDS

Overview
Catalog No.HW632013
Species reactivityHuman
ApplicationsELISA, WB
Host speciesHuman
IsotypeIgG4, kappa
Clone IDSAA2016
Clonality Monoclonal
Tested applications WB
Target IL13, NC30, Interleukin-13, IL-13
Endotoxin level Please contact with the lab for this information.
Purity >95% as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession P35225
RRID

Anti-Human IL13 Antibody (SAA2016) (abinScience Cat# HW632013, RRID:AB_3727928)
_x005F_x000D_

Form Liquid
Storage buffer 0.01M PBS pH 7.4

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Product Usage Information
Application Dilution
ELISA 1:2000-1:20000
WB 1:500-1:2000
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Background

Interleukin-13 (IL13) is a ~15 kDa protein. Cytokine that plays important roles in allergic inflammation and immune response to parasite infection. Synergizes with IL2 in regulating interferon-gamma synthesis. Stimulates B-cell proliferation, and activation of eosinophils, basophils, and mast cells. Plays an important role in controlling IL33 activity by modulating the production of transmembrane and soluble forms of interleukin-1 receptor-like 1/IL1RL1. Displays the capacity to antagonize Th1-driven proinflammatory immune response and downregulates synthesis of many proinflammatory cytokines including IL1, IL6, IL10, IL12 and TNF through a mechanism that partially involves suppression of NF-kappa-B.

1. Minty, A. et al. (1993) Nature 362, 248-50. PMID: 8096327
2. McKenzie, AN. et al. (1993) Proceedings of the National Academy of Sciences of the United States of America 90, 3735-9. PMID: 8097324
3. Defrance, T. et al. (1994) The Journal of experimental medicine 179, 135-43. PMID: 7903680
4. Luttmann, W. et al. (1996) Journal of immunology (Baltimore, Md. : 1950) 157, 1678-83. PMID: 8759755
5. Schnyder, B. et al. (1996) Blood 87, 4286-95. PMID: 8639787
6. Miloux, B. et al. (1997) FEBS letters 401, 163-6. PMID: 9013879
7. Kasaian, MT. et al. (2011) Journal of immunology (Baltimore, Md. : 1950) 187, 561-9. PMID: 21622864
Note For research use only.
Images
  • Anti-Human IL-13 Recombinant Antibody (SAA2016)

    Bioactivity

    SEC-HPLC detection for Anti-Human IL13 Antibody (ABS1981).

  • Anti-Human IL-13 Recombinant Antibody (SAA2016)

    SDS-PAGE

    SDS-PAGE for Anti-Human IL13 Antibody (SAA2016).

  • Anti-Human IL-13 Recombinant Antibody (SAA2016)

    Western blot

    Western blot analysis was performed using anti-IL13 monoclonal antibody at 1μg/ml on various samples.
    Lane 1: recombinant human IL13 (Catalog No: HW632012), 50ng
    Lane 2: recombinant human IL13 (Catalog No: HW632012), 30ng
    Lane 3: recombinant human IL13 (Catalog No: HW632012), 20ng

References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: support@abinScience.com

Distributor list